# Study of Viziatek ISL™ Refractive Phakic Intra Sulcus Lens for Refraction Adjustment in Blind Volunteers

> **NCT05518344** · NA · TERMINATED · sponsor: **Hanita Lenses** · enrollment: 4 (actual)

## Conditions studied

- Myopia

## Interventions

- **DEVICE:** Viziatek ISL™ (hereinafter referred to as the "ISL") implanted in blind eye.

## Key facts

- **NCT ID:** NCT05518344
- **Lead sponsor:** Hanita Lenses
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-06-04
- **Primary completion:** 2022-03-16
- **Final completion:** 2022-03-16
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Sponsor decision to terminate the study
- **Last updated:** 2022-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05518344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05518344, "Study of Viziatek ISL™ Refractive Phakic Intra Sulcus Lens for Refraction Adjustment in Blind Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05518344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*